Alkermes Inc. plc (ALKS)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.27 (+0.87%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Alkermes Inc. plc (ALKS)
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Key Insights

Critical company metrics and information
  • Share Price

    $31.46
  • Market Cap

    $5.09 Billion
  • Total Outstanding Shares

    161.80 Million Shares
  • Total Employees

    2,100
  • Dividend

    No dividend
  • IPO Date

    July 16, 1991
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.alkermes.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$-251.42 Million
Net Cash Flow$-251.42 Million
Net Cash Flow From Operating Activities$355.96 Million
Net Cash Flow From Investing Activities, Continuing$-118.42 Million
Net Cash Flow From Financing Activities$-488.97 Million
Net Cash Flow From Investing Activities$-118.42 Million
Net Cash Flow From Financing Activities, Continuing$-488.97 Million
Net Cash Flow From Operating Activities, Continuing$355.96 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Diluted Average Shares$337.73 Million
Revenues$1.51 Billion
Net Income/Loss Attributable To Parent$333.35 Million
Benefits Costs and Expenses$1.17 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Net Income/Loss$333.35 Million
Costs And Expenses$1.19 Billion
Other Operating Expenses$10.08 Million
Income/Loss From Continuing Operations Before Tax$332.18 Million
Diluted Earnings Per Share$1.98
Preferred Stock Dividends And Other Adjustments$0.00
Basic Average Shares$331.75 Million
Income Tax Expense/Benefit, Deferred$-20.20 Million
Operating Expenses$939.20 Million
Nonoperating Income/Loss$19.60 Million
Cost Of Revenue$253.34 Million
Basic Earnings Per Share$2.01
Operating Income/Loss$312.58 Million
Net Income/Loss Available To Common Stockholders, Basic$333.35 Million
Income/Loss From Discontinued Operations Net Of Tax$-53.61 Million
Income/Loss From Continuing Operations After Tax$386.95 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income Tax Expense/Benefit$-54.78 Million
Research and Development$261.08 Million
Gross Profit$1.25 Billion
Selling, General, and Administrative Expenses$668.03 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Accounts Receivable$367.21 Million
Wages$55.90 Million
Inventory$191.09 Million
Current Assets$1.56 Billion
Other Current Liabilities$360.76 Million
Equity Attributable To Parent$1.29 Billion
Equity Attributable To Noncontrolling Interest$0.00
Liabilities And Equity$2.16 Billion
Equity$1.29 Billion
Current Liabilities$453.70 Million
Accounts Payable$37.04 Million
Fixed Assets$225.42 Million
Liabilities$863.18 Million
Other Current Assets$1.01 Billion
Noncurrent Assets$591.11 Million
Other Non-current Assets$365.69 Million
Assets$2.16 Billion
Noncurrent Liabilities$409.48 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Alkermes Inc. plc (ALKS)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.